Fig. 1From: Comparison of the regressive effects of aflibercept and brolucizumab on pigment epithelial detachmentChanges in the maximum height (MH) of pigment epithelial detachment measured in the intravitreal aflibercept (IVA) and intravitreal brolucizumab (IVBr) groups before and at 1, 2, and 3 months after the first treatment. *: P < 0.05, ***: P < 0.001, ****: P < 0.0001Back to article page